1.50% Senior Convertible Notes
Amyris (NASDAQ:AMRS) is a synthetic biotechnology company and a supplier of substantiable and natural ingredients. The Company engineers microbes and uses them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that are manufactured at industrial scale. The Company has its own family of consumer brands and a partnership model where revenue is generated from the sale of molecules to partners and royalty revenue is earned from the partners’ sales of products to their customers.